BCIQ Profiles

Company Profile Report
0625 Abernethy Verily
BioCentury & Getty Images

Politics, Policy & Law

Abernethy’s appointment sheds light on Verily’s plans

Verily to develop clinical research tools, conduct research for itself and others

Verily is planning to develop clinical research tools and conduct research for itself and others.

Jun 25, 2021 | 8:56 PM GMT

Verily’s hiring of Amy Abernethy, who recently stepped down as FDA’s principal deputy commissioner, sheds some light on the company’s plans for its healthcare businesses, including conducting clinical trials for itself and for life sciences companies, and developing and selling

Read the full 870 word article

How to gain access

Continue reading with a
two-week free trial.